非限制性饮食不增加造血干细胞移植后中性粒细胞减少期间的感染:多中心随机试验数据
该多中心随机非劣效试验纳入222例接受大剂量诱导化疗或造血干细胞移植(HSCT)的连续成人患者,比较非限制性饮食(NRD)与低微生物保护性饮食(PD)。两臂中性粒细胞减少期间≥2级感染发生率及死亡无显著差异,NRD组患者自报满意度更高;作者结论为NRD不劣于传统PD。
要点
- HSCT后中性粒细胞减少期间,非限制性饮食与保护性饮食的≥2级感染发生率无显著差异。
- 两臂住院时长、黏膜炎与胃肠道感染发生率、体重及血清白蛋白变化均无显著差异。
- NRD与更高的患者自报满意度相关;作者结论为NRD不劣于传统PD。
核心结论
- 在HSCT后中性粒细胞减少期间,非限制性饮食(NRD)不劣于传统保护性饮食(PD)。
- 作者认为实施限制性饮食给患者生活质量带来不必要的负担。
研究设计与样本
- 多中心、随机、非劣效试验,连续纳入接受大剂量诱导化疗或HSCT的成人患者。
- 共222例患者入组、随机分组并纳入分析;175例(79%)接受自体HSCT,41例(18%)接受异基因HSCT,6例(3%)接受大剂量诱导化疗。
- 试验在米兰国家肿瘤研究所临床试验注册中心前瞻性注册,注册号INT54/16。
主要发现
- 两臂中性粒细胞减少期间≥2级感染发生率及死亡无显著差异。
- 多因素分析中,仅多发性骨髓瘤诊断、氟喹诺酮类预防用药及无黏膜炎与较低的≥2级感染发生率相关。
- 两臂住院时长、黏膜炎和胃肠道感染发生率、体重及血清白蛋白变化均无显著差异。
- 异基因HSCT受者中,≥3级急性移植物抗宿主病发生率相似。
- NRD与更高的患者自报满意度相关。
临床怎么用
- 原文结论为NRD不劣于传统PD,并指出实施限制性饮食给患者生活质量带来不必要的负担。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Infections are a major cause of morbidity and mortality during neutropenia after hematopoietic stem cell transplantation (HSCT). The use of a low-microbial protective diet (PD) in the peritransplantation period is a standard of care, although its efficacy has never been tested prospectively. We conducted a multicenter, randomized, noninferiority trial, enrolling all consecutive adult patients undergoing high-dose induction chemotherapy or HSCT with the objective to compare nonrestrictive diet (NRD) vs PD. Overall, 222 patients were enrolled, randomly assigned, and analyzed. One hundred seventy-five subjects (79%) received autologous HSCT (auto-HSCT), 41 (18%) received allogeneic HSCT (allo-HSCT), and 6 (3%) patients received high-dose induction chemotherapy. There was no significant difference in terms of incidence of grade ≥2 infections and death during neutropenia in the 2 arms. In multivariable analysis, only multiple myeloma diagnosis, fluoroquinolone prophylaxis, and the absence of mucositis were associated with a lower incidence of grade ≥2 infections. We did not report any significant variation in terms of hospitalization length, incidence of mucositis and gastrointestinal infections, body weight, and serum albumin variations in the 2 arms. In allo-HSCT recipients, the incidence of acute graft-versus-host disease grade ≥3 was similar. NRD was associated with higher patient-reported satisfaction. In conclusion, NRD is not inferior to a traditional PD during neutropenia after HSCT, and our results demonstrated that implementing a restrictive diet unnecessary burdens patients' quality of life. The clinical trial was registered prospectively in the clinical trial registry of the Istituto Nazionale dei Tumori of Milan as INT54/16.
引用
- Stella F, Marasco V, Levati GV, et al. Nonrestrictive diet does not increase infections during post-HSCT neutropenia: data from a multicenter randomized trial. Blood Adv. 2023. PMID: 37450382. doi:10.1182/bloodadvances.2023010348
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。